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Background. Seasonal increases in malaria continue in hot spots in Zanzibar. Mass screening and treatment
(MSAT) may help reduce the reservoir of infection; however, it is unclear whether rapid diagnostic tests (RDTs)
detect a sufﬁcient proportion of low-density infections to inﬂuence subsequent transmission.
Methods. Two rounds of MSAT using Plasmodium falciparum–speciﬁc RDT were conducted in 5 hot spots
(population, 12 000) in Zanzibar in 2012. In parallel, blood samples were collected on ﬁlter paper for polymerase
chain reaction (PCR) analyses. Data on conﬁrmed malarial parasite infections from health facilities in intervention
and hot spot control areas were monitored as proxy for malaria transmission.
Results. Approximately 64% of the population (7859) were screened at least once. P. falciparum prevalence, as
measured by RDT, was 0.2% (95% conﬁdence interval [CI], .1%–.3%) in both rounds, compared with PCR measured
prevalences (for all species) of 2.5% (95% CI, 2.1%–2.9%) and 3.8% (95% CI, 3.2%–4.4%) in rounds 1 and 2, respec-
tively. Two ﬁfths (40%) of infections detected by PCR included non-falciparum species. Treatment of RDT-positive
individuals (4% of the PCR-detected parasite carriers) did not reduce subsequent malaria incidence, compared with
control areas.
Conclusions. Highly sensitive point-of-care diagnostic tools for detection of all human malaria species are needed
to make MSAT an effective strategy in settings where malaria elimination programs are in the pre-elimination phase.
Keywords. malaria elimination; mass screening and treatment; diagnostic tests; Zanzibar; subpatent; molecular
methods; Plasmodium falciparum; Plasmodium vivax; Plasmodium malariae; Plasmodium ovale.
Malarial parasite infection among patients with fever
has reduced signiﬁcantly in Zanzibar over the past
decade, from approximately 40% to <1%, following
wide-scale deployment of multiple malaria control in-
terventions [1–3].Malaria transmission is now seasonal
and focal, with 80% of the cases recorded in 2013 re-
ported from 20% of public health facilities [3]. Such
malaria foci are a well-documented phenomenon in
low transmission areas [4–6] and can be targeted for
transmission reduction strategies [7].
Zanzibar’s primary surveillance system for malaria is
theMalaria Early EpidemicDetection System (MEEDS),
involving all public health facilities reporting (via mo-
bile phone) weekly numbers of conﬁrmed malaria
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cases (using rapid diagnostic tests [RDTs] or microscopy)
among febrile patients tested [8]. This system detects sympto-
matic malarial parasite infections that involve relatively high
parasite densities. Many studies have described asymptomatic
low-density infections as a substantial reservoir of infection in
settings of low and high transmission [9–13]. In Zanzibar, little
is known about the magnitude of asymptomatic parasite carri-
ers and their importance for sustained transmission.
Mass screening and treatment (MSAT) aims to detect and
treat all malarial parasite infections, including asymptomatic
parasite carriers, within the community [14]. The aim is to re-
duce the parasite reservoir (using multiple screening rounds)
before the transmission season, with the intention of limiting
onward transmission. The diagnostic tool usually used is an
RDT, due to its ease of use and quick results. RDTs have
well-documented limitations, including limited sensitivity for
low-density falciparum (ie, <100 parasites/µL), and non-
falciparum infections [15, 16]. Molecular methods, such as
polymerase chain reaction (PCR), have demonstrated sen-
sitivities as low as 0.02 parasites/µL [17], but currently there
are few options for using this method for point-of-care
diagnosis.
This study evaluated the impact of MSAT, using P. falciparum–
speciﬁc RDT and artesunate-amodiaquine (ASAQ), on malaria
incidence in Zanzibar. To determine the overall prevalence of
malarial parasite infection, including low-density and non-
falciparum infections not detected by the RDT, blood samples
collected on ﬁlter paper underwent molecular analyses.
METHODS
Study Areas
Zanzibar is a semi-autonomous archipelago in Tanzania, located
approximately 35 km from the coast of the mainland (popul-
ation, approximately 1.3 million). Zanzibar is a malaria pre-
elimination setting; transmission is low [18] and seasonal,
with the majority of symptomatic cases recorded following
the long rains, which occur from March to May.
MEEDS data from 2010 to 2011 were used to rank all public
health facilities on Unguja island on the basis of malaria-
positive test results and annual incidence of malaria infections
per 1000 catchment population. The shehias (administrative units
with populations up to 3000 people) served by the top-ranking
health facilities were deﬁned as hot spots. Twelve hot spot shehias
were selected for the study. Five shehias (served by 3 public health
facilities) were selected to be intervention shehias (4 from the
central region [Jumbi, Tunguu, Bungi, and Ukongoroni] and 1
from the southern region [Mtende]; Figure 1). The remaining 7
shehias (served by 4 health facilities) were designated control she-
hias where MSAT was not performed. The intervention and con-
trol areas were chosen on the basis of similar transmission
patterns, location, and population size.
When the study was designed, the estimated population of
the intervention and control areas was approximately 10 000
each. However, the 2012 Tanzanian census estimated the pop-
ulation in the intervention area to be approximately 12 000.
MSAT Intervention
The intervention took place in May and June 2012 (weeks 20
and 24), before the onset of the expected seasonal increase of
cases. Two rounds of household MSAT were conducted over
4 days each, with an interval of 4 weeks between rounds. The
study aimed to include every household in the intervention she-
hias, but if the house was empty when visited, it was excluded
for that round. Every person living permanently in the house-
hold was documented, even if not present, to estimate the per-
centage of the target population screened. Every household
member was asked to provide a blood specimen by ﬁnger
prick for an RDT and for dried blood spot analysis. The
blood spot specimens were sent to Sweden for molecular anal-
yses and stored at 4°C until use.
Malaria Indices
RDT
The RDT used for the study was Paracheck Pf(Orchid Biomed-
ical Systems, India), in accordance with Zanzibar national
guidelines at the time of the study. Paracheck Pf detects
P. falciparum–speciﬁc histidine rich protein 2 (HRP-2). Partic-
ipants with positive RDT results were provided treatment with
ASAQ, as per national guidelines.
PCR
The prevalence of low-density and non-falciparum infections
was assessed using PCR analysis of blood spot specimens (ap-
proximately 50 µL of blood; Whatman 3MM) from participants
in the intervention sites. Molecular analyses took place in Swe-
den (Karolinska Institutet, Stockholm). The Chelex boiling
method [19] was used to extract DNA from a 3-mm diameter
punch from the blood spot specimens, and the cytochrome b
(cytb) quantitative PCR (qPCR) with the SYBR Green real-
time PCR assay, targeting the Plasmodium cytochrome b gene
(Xu et al, unpublished data, 2014), was used for infection detec-
tion. DNA extraction was performed on pools of 6 samples [20]
followed by duplicate cytb qPCR analysis, using 2 µL of extract-
ed DNA as template. Each sample from Plasmodium-positive
pools was individually extracted and subjected to cytb qPCR
in duplicate, using 5 µL of extracted DNA as template. Plas-
modium-positive specimens from this step underwent reextrac-
tion of DNA in duplicate and were subjected to cytb qPCR
analysis in triplicate (using 5 µL DNA as template). The sam-
ples were deﬁned as Plasmodium positive if results of at least
one out of six of the ﬁnal PCR analyses were positive. Positive
and negative controls were incorporated into each PCR run.
The detection limit for the cytb qPCR method for single
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DNA extraction is approximately 1–2 parasites/µL blood for
Plasmodium species (Xu et al, unpublished data, 2014). Restric-
tion fragment–length polymorphism analysis and sequencing
of the cytb qPCR product was used for species determination.
An 18S qPCR method was used for parasite density quanti-
ﬁcation [21]. Brieﬂy, samples with known densities of Plasmo-
dium species were serially diluted, dropped on ﬁlter papers, air
dried, and subjected to DNA extraction. 18S qPCR [21] was
performed on the extracted DNA, and a standard curve was
plotted using the quantiﬁcation cycle (Cq) value and parasite
density (parasites/µL). The mean Cq values from triplicate
runs were calculated from the study samples.
Data Analysis
Data were double entered using CS Pro software. All analyses
were done in Stata, version 12.1 (StataCorp, College Station,
TX). Prevalence and 95% conﬁdence intervals (CIs) and
P values from χ2 tests were calculated using binomial exact
methods, adjusting for clustering within households and she-
hias. Differences between shehia, age group, and sex were inves-
tigated separately for each round of screening. For RDT
sensitivity and speciﬁcity analyses, data from the 2 rounds
were pooled, and the ﬁnal PCR outcome for P. falciparum infec-
tions was deﬁned as gold standard.
To assess subsequent transmission, malaria data were collect-
ed from 3 and 5 health facilities in the intervention and control
areas, respectively. Diagnosis in the health facilities was made
using P. falciparum–speciﬁc RDT or microscopy; only febrile
patients were tested, according to national guidelines. Numbers
of cases and the weekly and monthly incidence of malaria, de-
ﬁned as the number of cases per 1000 catchment facility popu-
lation, were monitored until the end of 2012 and used as an
indicator for transient ﬂuctuations in transmission. Monthly in-
cidences in the intervention and control sites following the
survey were assessed using a generalized least squares random-
effects model to account for differences between facilities.
Figure 1. Map of control (striped) and intervention (grey) study shehias and health facilities (black dot), Unguja Island, Zanzibar.
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Ethical Considerations
Before implementation, the study aims were described to the
community leaders of each intervention area. During the
screening, informed consent was obtained from each household
head. The study was considered part of the Zanzibar Ministry of
Health malaria surveillance strategy, and therefore it was
deemed unnecessary to obtain ethical approval within Zanzibar.
Ethical approval was granted through the Regional Ethics
Review Board, Stockholm, Sweden (2013/836–32), and the
Centers for Disease Control and Prevention determined that
the study was a nonresearch activity.
RESULTS
MSAT Coverage
Overall, 86% of the census population in the intervention areas
was documented by study enumerators (10 295 individuals).
Approximately 17% (1786 individuals) of the enumerated pop-
ulation was absent for both rounds of screening. Of those pre-
sent in each round, 4% (278 individuals) and 13% (723
individuals) refused to take part in the study in the ﬁrst and sec-
ond rounds, respectively. Based on census data, 53% (6389 in-
dividuals) and 43% (5046 individuals) of the target population
was screened in rounds 1 and 2, respectively. In total, 76% of
enumerated individuals (7859 of 10 295) were screened by
RDT at least once, representing 64% of the population. The me-
dian age in both rounds was 19 years (range, 1 month–100 years).
Overall, more females were tested than males (60% vs 40%). This
difference was most pronounced between the ages of 15 and 50
years, in which over two thirds of people tested were female.
Malaria Indices
Prevalence of RDT-Detectable P. falciparum Infections
Twelve P. falciparum infections (0.2%; 95% CI, .1%–.3%) were
detected using RDT in the ﬁrst round. Ten of these were con-
ﬁrmed by PCR. RDT-detected infections were found in all she-
hias except Mtende (Table 1). Children aged 5–15 years had the
highest RDT positivity rate (0.5%). No infections were detected
in the oldest age group (50–100 years), and only 1 infection was
found among children aged <5 years (Table 1).
In the second round, 8 P. falciparum infections (0.2%; 95%
CI, .1%–0.3%) were detected using RDT. Four of these were
conﬁrmed by PCR. As in the ﬁrst round, infections were detect-
ed in all shehias except Mtende. Two of the RDT-positive indi-
viduals in the second round had received treatment within the
previous 2 weeks (both were PCR negative). All RDT-positive
individuals were aged 8–28 years.
Prevalence of PCR-Detectable Malarial Parasite Infections
The prevalence of P. falciparum infections detected by PCR was
signiﬁcantly higher than the prevalence detected by RDT
(P < .001), with values of 2.1% (95% CI, 1.7%–2.5%) and 2.6%
(95% CI, 2.1%–3.1%) in the ﬁrst and second rounds, respecti-
vely (Table 2). PCR identiﬁed 37 and 100 non-falciparum
infections in rounds 1 and 2, respectively; 40% of these
were mixed infections with P. falciparum. The PCR-based prev-
alence of Plasmodium was 2.5% (95% CI, 2.1%–2.9%) and 3.8%
(95% CI, 3.2%–4.4%; P < .001) in the ﬁrst and second rounds,
respectively.
Table 1. Malarial Parasite Infection Prevalence and Distribution
Across Age Group, Sex, and Geographical Distribution, by Rapid
Diagnostic Testing (RDT) and Polymerase Chain Reaction (PCR)
Analysis, in Rounds 1 and 2 of Mass Screening and Treatment,
Unguja Island, Zanzibar
Variable
RDT-Based Prevalence,
No. (%)
PCR-Based Prevalence,
No. (%)
Round 1
(n = 6381)
Round 2
(n = 5046)
Round 1
(n = 6233)
Round 2
(n = 4894)
Overall 12 (0.2) 8 (0.2) 154 (2.5) 185 (3.8)
Age, y
0–5 1 (0.1) 3 (0.3) 24 (1.7) 32 (3.0)
5–15 7 (0.5) 2 (0.2) 40 (2.9) 48 (4.0)
15–25 2 (0.2) 1 (0.1) 43 (3.7) 36 (4.3)
25–50 2 (0.1) 2 (0.3) 32 (1.9) 51 (4.0)
50–100 0 (0.0) 0 (0.0) 15 (2.6) 17 (3.6)
Sex
Female 8 (0.2) 3 (0.1) 77 (2.1) 108 (3.7)
Male 4 (0.2) 5 (0.3) 77 (2.9) 77 (4.0)
Location
Bungi 1 (0.1) 3 (0.3) 35 (2.7) 35 (3.8)
Tunguu 5 (0.4) 2 (0.2) 32 (2.4) 39 (3.8)
Jumbi 4 (0.2) 1 (0.1) 53 (2.9) 53 (3.6)
Ukongoroni 2 (0.3) 2 (0.3) 8 (1.1) 36 (5.8)
Mtende 0 (0.0) 0 (0.0) 26 (2.5) 22 (2.6)
Table 2. Plasmodium Species Detected by Polymerase Chain
Reaction Analysis Among Malarial Parasite–Positive Specimens
in Rounds 1 and 2, Unguja Island, Zanzibar
Species
Round 1, No. (%)
(n = 154)
Round 2, No. (%)
(n = 185)
P. falciparum 117 (76.0) 84 (45.4)
P. falciparum, P. malariae 13 (8.4) 27 (14.6)
P. falciparum, P. malariae,
P. ovale
0 5 (2.7)
P. falciparum, P. ovale 0 9 (4.9)
P. falciparum, P. vivax 0 1 (0.5)
P. malariae 21 (13.6) 35 (18.9)
P. malariae, P. ovale 0 9 (4.9)
P. malariae, P. ovale,
P. vivax
0 2 (1.1)
P. malariae, P. vivax 0 1 (0.5)
P. ovale 2 (1.3) 10 (5.4)
P. vivax 1 (0.6) 2 (1.1)
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Malarial parasite infections were detected by PCR in all she-
hias and in all age groups (Table 1). In the ﬁrst round, children
aged <5 years had the lowest prevalence (1.7%), with persons
aged 15–25 years and those aged 25–50 years demonstrating
the highest prevalence (2.9% and 3.7%, respectively; P = .008).
In the second round, infections were evenly distributed over
the age groups (Table 1).
Plasmodium Species Determination by PCR
The numbers of Plasmodium infections detected in each round
are summarized in Table 2. Of the monoinfections detected by
PCR, the majority were P. falciparum (83.0% in round 1 and
64.6% in round 2). Plasmodium malariae infection was the
most common non-falciparum infection (14.9% and 26.2% of
single infections in rounds 1 and 2, respectively), followed by
Plasmodium ovale infection (1.4% and 7.7%, respectively).
One Plasmodium vivax monoinfection was detected in the
ﬁrst round (the same individual tested negative for P. vivax in
the second round) and 2 were detected in the second round.
Four additional P. vivax infections were detected as part of a
mixed infection in the second round (Table 2).
In the ﬁrst round, 8.4% of the infections (13) were mixed
P. falciparum/P. malariae. The prevalence of mixed infections
increased to 29.3% (54) in the second round (Table 2). Mixed
infections were only found in people aged 5–50 years in the ﬁrst
round (P = .042) but were evenly distributed across age groups
in the second round (P = .870; Figure 2).
P. falciparum infections were distributed unevenly between
shehias in both rounds (P = .06 in round 1 and P < 0.001 in
round 2). Age was not associated with P. falciparum, P. ovale,
or P. vivax infection, but in the ﬁrst round people aged 15–25
years were more likely to be PCR positive for P. malariae
(P = .001). This difference was not detected in the second round.
Parasite Density Determined by qPCR
qPCR was able to determine parasite density in 84% of samples
(130) and 89% of samples (164) with positive 18S qPCR results in
the ﬁrst and second rounds, respectively (Table 3). The geometric
mean parasite density was 4.1 parasites/μL (range, 0.1–16 130
parasites/μL) and 2.2 parasites/μL (range, 0.1–39 352 parasites/
μL) in the ﬁrst and second rounds, respectively. There was no
association between parasite density and age (P = .563).
PCR Analysis of Paired Blood Samples From Rounds 1
and 2
Paired blood samples from the ﬁrst and second rounds were avail-
able from 3268 participants (42% of total samples). Of these
paired PCR results, 94% (3071) were negative and 0.2% (7)
were positive in both rounds. Two percent (66) were positive in
the ﬁrst round but negative in the second round, whereas 4%
(124) were negative in the ﬁrst round but positive in the second
round. Of the 66 who were positive in the ﬁrst round but negative
in the second, 90% had qPCR-determined parasite densities of
<100 parasites/µL. Of the 124 who were negative in the ﬁrst
round but positive in the second round, only 2 had a parasite den-
sity of >100 parasites/µL. The parasite densities in the 7 matched
positive samples were similar to those positive in only 1 round.
Sensitivity and Speciﬁcity of RDT for Detection of
P. falciparum
Of 20 RDT-positive results, 14 (10 in the ﬁrst round and 4 in the
second round) were conﬁrmed by PCR to be P. falciparum pos-
itive. This equates to treatment for 4% of people (14 of 332) with
Table 3. Parasite Density Determined by Quantitative
Polymerase Chain Reaction Analysis in Rounds 1 and Round 2,
Unguja Island, Zanzibar
Parasites/μL of Blood Round 1 Round 2
Not quantifiable 24 (15.6) 21 (11.4)
0.1–10 88 (57.1) 127 (68.7)
10–50 20 (13.0) 28 (15.1)
50–100 7 (4.6) 1 (0.5)
100–500 9 (5.8) 3 (1.6)
500–5000 6 (3.9) 5 (2.7)
Total 154 185
Data are no. or no. (%) of samples
Figure 2. Prevalence of Plasmodium species, by polymerase chain reac-
tion (PCR) ﬁndings, across age groups in round 1 (A) and round 2 (B).
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PCR-detectable infections. Three of 6 RDT-positive/PCR-nega-
tive individuals reported intake of antimalarial treatment in the
previous 2 weeks. The RDT sensitivity and speciﬁcity, com-
pared with qPCR, for P. falciparum detection was 5.6% (95%
CI, 3.1%–9.2%) and 99.9% (95% CI, 99.8%–100.0%), respec-
tively. However, the RDT sensitivity increased when the analysis
was restricted to P. falciparum densities of >100 parasites/µL
(47.6%; 95% CI, 25.7%–70.2%).
Passively Collected Health Facility Data on Conﬁrmed
Malarial Parasite Infections
Passive case detection using RDT/microscopy continued as
usual in the public health facilities in the intervention and con-
trol areas. In the week following the second screening (week 25),
the number of RDT/microscopy-positive cases recorded in the
control area peaked at 10, with a peak of 7 recorded in the in-
tervention area (Figure 3). In the 4 weeks following the second
round of MSAT, 9 infections were detected at the Ukongoroni
public health facility, contributing 50% of the total number of
cases reported in all intervention health facilities during that
time. The increase in cases was lower than that during the same
period in the previous 2 years in intervention and control areas.
The average weekly incidence peaked at 1.6 and 0.6 cases per
1000 persons in the intervention and control areas in the weeks
following the second round of screening (Figure 3). There was no
difference in average monthly incidence between control and in-
tervention areas at any point through to the end of 2012 (P = .746).
DISCUSSION
This study suggests that MSAT using P. falciparum–speciﬁc
RDT as the diagnostic tool did not reduce subsequent malaria
incidence, probably because only a minority (4% [14 of 332]) of
the overall parasite carriers (as assessed by PCR) were detected
and treated. More-sensitive point-of-care diagnostic tools are
needed if MSAT interventions are going to be a useful strategy
in pre-elimination settings [22]. A lack of impact following
RDT-based MSAT has also been seen in Burkina Faso and
Kenya [23, 24].While these studies did not include a molecular
diagnostic tool, it is possible that underlying subpatent infec-
tions, which were able to sustain transmission in the communi-
ty, reduced the effects of the MSAT. An ideal solution would be
a ﬁeld-based PCR that can be used as a point-of-care diagnostic
test [25, 26]. Field trials using a loop-mediated isothermal am-
pliﬁcation kit (LAMP) [25, 27] have since been performed in
Zanzibar.
While the low proportion of the parasite reservoir treated is
probably the main reason there was no inﬂuence on subsequent
incidence in our study, it is likely that the low population cov-
erage also played a role. Absenteeism was a problem, particular-
ly in the second round. School children and working adults are
not necessarily present in their homes throughout the day, and
in this study, owing to logistic reasons, it was not possible to fol-
low up absent household members. One way of overcoming this
problem would be to visit households in the evenings, when
people are more likely to be present, or to visit schools to ensure
all school age children are screened [24]. Young men were par-
ticularly likely to be absent and were also most likely to refuse
screening. In the ﬁrst round of screening, males and people aged
15–25 years showed the highest infection rates, as has been re-
ported in other settings of low endemicity [28, 29], and it is pos-
sible that screening with RDT would have been more effective if
these risk groups had been better represented. A proportion of
the absences may have been through community members ac-
tively choosing not to be available for screening, as the levels of
absences and refusals were much higher in the second round.
Figure 3. Number of conﬁrmed malarial parasite infections reported from public health facilities (bars) and average weekly incidence in the control and
intervention areas (lines). Screening occurred in weeks 20 and 24.
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This highlights the importance of an effective community sen-
sitization campaign before repeated screening rounds.
P. falciparum was the main species detected during the study.
However, the proportion of non-falciparum infections detected
in Zanzibar has been increasing in recent years. Two studies in
2013 found that 20% and 50% of infections detected using
molecular methods were non-falciparum (unpublished data).
In this study, the majority of the non-falciparum infections
were of very low densities; however, detecting and clearing
non-falciparum infections may become relatively more impor-
tant as P. falciparum infections decrease further, as has been
seen in other settings [30, 31]. Importantly, the presence of
P. vivax has only been reported once previously in Zanzibar
[32] and may pose a problem for elimination efforts.
Approximately 40% of the screened population was tested in
both rounds, with many showing dichotomous PCR results.
Several studies have demonstrated similar ﬁndings of ﬂuctua-
tions in parasite densities in settings of high [33, 34] and low
[6] transmission. With such a high proportion of low-density
parasitemias present in the study area, it is likely that many
are on the cusp of detectability. However, importantly, the
number of new infections detected in the second round high-
lights the importance of several screening rounds, even when
sensitive diagnostic tests are used.
The second round had a higher prevalence of malarial para-
site infections (3.8%), particularly non-falciparum infections.
This increase may be related to rainfall that occurred between
the 2 rounds, resulting in further spread of cases. However, it
is not clear why this would particularly apply to non-falciparum
infections. Temporal studies investigating transmission dynam-
ics between P. falciparum and P. malariae or P. ovale are lacking.
However, differential ﬂuctuation in prevalence has been report-
ed between P. falciparum and P. vivax in Cambodia [35], Van-
uatu [36], and Peru [37]. In Vietnam, different vectors are
thought to be responsible for the transmission of different spe-
cies [38], although this has not been recorded in Zanzibar. The
RDT now used in public health facilities in Zanzibar is SD Bi-
oline (Standard Diagnostics, Republic of Korea), which is able
to detect HRP-2 antigen speciﬁc to P. falciparum and pLDH
speciﬁc to other Plasmodium species.
The study had several limitations, particularly related to the
evaluation of subsequent transmission. Passive case detection is
not an ideal proxy for onward transmission because it only detects
symptomatic cases and is dependent on health facility utilization.
A more effective measure of subsequent transmission would be to
continue active case detection in the communities, using molec-
ular methods, for several months after the intervention. In addi-
tion, while we have a reasonably accurate population measure
through the census, we cannot be certain that catchment areas as-
signed to facilities are accurate. While this may have affected the
estimated incidence, the low numbers of cases treated during the
intervention suggest that little impact would have been seen.
Bearing in mind the low sensitivity of current diagnostic tools
available for the ﬁeld, further understanding of the clustering of
malaria cases and the possibility of delivering targeted pre-
sumptive treatment to those living near to RDT-positive cases
or of implementing seasonal malaria mass drug administration
in hot spots of transmission could represent pragmatic options
to reduce the asymptomatic subpatent carriage of malarial par-
asites in Zanzibar, although the effectiveness of artemisinin-
combination therapy on low-density infections will need to be
considered [39, 40].
Malaria elimination was achieved in many parts of the world
before molecular tools were available to detect low-density in-
fections. The role that these infections play in transmission is
still under debate [41], and it seems likely that they are less likely
to transmit to mosquitoes than patent infections [42, 43]. How-
ever, in Zanzibar, where the mosquito vector is highly efﬁcient,
a high number of low-density infections is perhaps more likely
to result in onward transmission, and therefore they are an im-
portant part of the parasite reservoir to target.
In conclusion, this study demonstrates that MSAT based on
P. falciparum–speciﬁc RDT as a diagnostic tool did not reduce
subsequent malaria incidence in Zanzibar, probably because of
the large proportion of infections that were undetected by RDT
and thus untreated but also because of the low population
coverage. This highlights the importance of more-sensitive
point-of-care diagnostic tools that can detect all human malaria
species, if screen and treat programs are going to be a useful
strategy in malaria preelimination settings.
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